MINI FUTURE LONG - QUEST DIAGNOSTICS | Market Closed - Börse Stuttgart 18:53:36 14/06/2024 BST | ||
| 4.05 EUR | -0.74% |
|
| Current month | -6.47% | ||
| 1 month | -2.41% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 14/06/24 | 4.05 | -0.74% |
| 13/06/24 | 4.08 | 0.00% |
| 12/06/24 | 4.08 | -4.90% |
| 11/06/24 | 4.29 | -0.69% |
| 10/06/24 | 4.32 | -2.26% |
Delayed Quote Börse Stuttgart
Last update June 14, 2024 at 06:53 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | ME92BP |
| ISIN | DE000ME92BP5 |
| Date issued | 21/02/2024 |
| Strike | 94.98 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.94 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.7 € |
|---|---|
| Lowest since issue | 2.73 € |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
137.8
USD
Average target price
147
USD
Spread / Average Target
+6.64%
- Stock Market
- Certificates
- Certificat